About
Wellumio is a New Zealand-based medical technology company dedicated to enhancing acute stroke care with innovative portable magnetic resonance imaging (MRI) solutions. Founded in 2019 by Dr. Shieak Tzeng, the company focuses on delivering advanced brain imaging directly to patients' bedsides, which enables quicker and more accurate stroke diagnosis and intervention. The flagship product, the Axana device, is a compact, energy-efficient MRI scanner that provides rapid neuroimaging for stroke detection in various clinical settings, including emergency rooms and ambulances. Utilizing proprietary pulse gradient-free mapping technology, the Axana can deliver results in as little as four minutes, significantly speeding up the diagnostic process. Wellumio is actively conducting clinical trials and is preparing for FDA breakthrough device designation to facilitate market entry in the United States, aiming to make portable MRI technology widely accessible in healthcare facilities.
Technologies
Keywords
Company Information
-
Employees 13
-
Founded 2019
Location
155 The Terrace, Wellington, Wellington, New Zealand, 6011